Vaccinations

UK invests billions in new biosecurity centre to strengthen pandemic preparedness

UK invests billions in a National Biosecurity Centre in Essex: Europe’s largest hub for vaccine development, and pandemic preparedness.

Moderna create vaccine trial for children aged 6 months and over

Moderna are enrolling roughly 13,275 participants in their vaccine trial for children - with the participants aged between six months to 12 years.

Epidemiologist says reaching herd immunity with Delta is “mythical”

Sir Andrew Pollard, head of the Oxford Vaccine Group, said on Tuesday (10 August) that herd immunity is "mythical" in relation to the Delta variant - as it still infects vaccinated individuals.

COVID-19 booster jab will offer better protection against variants

COVID-19 booster jab will protect people from existing, and potentially future, variants, according to scientists at the University of Nottingham.

BMJ study explores potential for “eradication of COVID-19”

The BMJ Global Health study looks at how the "eradication of COVID-19" could work - if high vaccination happens in every country, and all vaccines remain up-to-date.

Moderna vaccine 93% effective six months after second dose

The Moderna vaccine appears to be 93% effective, six months after the second dose - but CEO Stéphane Bancel says "we must remain vigilant".

NHS says 20% of people hospitalised with COVID are young

New figures from the NHS show that 20% of people hospitalised with COVID right now are young - between the ages of 18 to 34.

WHO asks richer countries to hold off on third COVID doses

Dr Tedros Ghebreyesus, WHO leader, asked richer countries in the Global North to wait before giving third COVID jabs - as the Global South is yet to hit 10% double-vaccinated, due to low vaccine supply.

Pfizer-BioNTech vaccine to be offered to 16-17-year-olds

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that all 16 and 17-year-olds should receive their first dose of the Pfizer-BioNTech vaccine.

European commission approves contract for Novavax vaccine

The European Commission has approved a new contract that will allow Member States to purchase up to 100 million doses of the Novavax vaccine.

UK study finds long-term COVID effects rare in children

This UK-based study, published in The Lancet, finds that long-term COVID effects are rare in children - usually, the illness is over after six days.

Study finds that llama nanobodies can stop COVID-19

The study, published in Nature Communications, looks at how llama nanobodies can disarm and stop COVID-19 - creating a new type of future vaccination.

Clinical trial to investigate vaccine dose interval for pregnant women

A new clinical trial, funded by the UK government, will investigate the best gap between the first and second COVID-19 vaccine dose for pregnant women.

Study finds hydroxychloroquine most likely toxic to human genome

A study, published in the journal DNA Repair, finds that hydroxychloroquine (HCQ) is potentially toxic to mammals - the drug that was previously elevated to the status of miracle COVID cure in some circles.

Price of COVID vaccines to rise as they become variant-ready

France's Junior Minister for European Affairs, Clément Beaune, said that the price of COVID vaccines Pfizer and Moderna rose after being adapted for the Delta variant.

NHS say 170,000 Moderna jabs to expire in next two weeks

According to The Guardian, the NHS is concerned that 170,000 Moderna jabs will expire soon - as vaccine take-up in the 18-25 year old bracket slows down.

US study says racial disparities in vaccination problematic for 10 years

Scientists, looking at the US population, reveal that racial disparities in vaccination have been an ongoing issue for the last ten years.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders